Brief: Eloxx Pharmaceuticals Reports Third Quarter 2020 Financial And Operating Results And Provides Business Update
05/11/2020 22:34
Nov 5 (Reuters) - Eloxx Pharmaceuticals Inc ELOX.O :
* ELOXX PHARMACEUTICALS REPORTS THIRD QUARTER 2020 FINANCIAL
AND
OPERATING RESULTS AND PROVIDES BUSINESS UPDATE
* Q3 LOSS PER SHARE $0.16
* Q3 EARNINGS PER SHARE ESTIMATE $-0.19 -- REFINITIV IBES
DATA
Source text for Eikon: ID:nGNX4yVgnj
Further company coverage: ELOX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Eloxx Pharmaceuticals
See all newsNASDAQ RESUMED AT 02:24 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM
Brief: Eloxx Pharmaceuticals Provides ELX-02 And ZKN-013 Program Updates
Brief: Eloxx Pharmaceuticals Confirms That Alport Syndrome Patients Treated With Elx-02 In Phase 2 Study Had Improvement
Brief: Eloxx Pharmaceuticals Inc Reports Results In All Patients Treated With Elx-02 In Phase 2 Clinical Study For Alport Syndrome